ENOV ENOVIS CORPORATION

Enovis to Participate in Upcoming Investor Conferences

Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:

  • Jefferies London Healthcare Conference: Matt Trerotola, Chair and Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, November 20th at 12:00 p.m. GMT (7:00 a.m. ET)
  • Evercore 7th Annual HealthCONx Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, December 4th at 10:50 a.m. ET.

A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit .

Contact:

Kyle Rose

Vice President, Investor Relations

Enovis Corporation



EN
18/11/2024

Underlying

ENOVENOVIS CORPORATION

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ENOVIS CORPORATION

 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis™ Announces Leadership Change to International Surgical Business

Enovis™ Announces Leadership Change to International Surgical Business Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin Reinmann as President of Enovis International Surgical, effective March 1, 2025. Visentin is a successful MedTech executive who comes to Enovis with more than 20 years of healthcare experience. Most recently, he was the Vice President and General Manager of the Integrated Diagnostic Solutions Business Unit for BD, where h...

January 17, 2025 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Confer...

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference Wilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 43nd Annual J.P. Morgan Healthcare Conference with a presentation scheduled for Monday, January 13th, 2025, at 9:45 a.m. PST (12:45 p.m. EST). A link to the live audio webcast, as well as a copy of the accompanying presentation slides and a replay of this event, will be available on the company’s website ...

January 6, 2025 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis to Participate in Upcoming Investor Conferences

Enovis to Participate in Upcoming Investor Conferences Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Jefferies London Healthcare Conference: Matt Trerotola, Chair and Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, November 20th at 12:00 p.m. GMT (7:00 a.m. ET)Evercore 7th Annual HealthCONx Conference: Ben Berry, Chief Financial Off...

November 18, 2024 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis Announces Third Quarter 2024 Results

Enovis Announces Third Quarter 2024 Results Continued commercial momentum with third-quarter sales growth of 21% on a reported basis and strong adjusted EBITDA margin expansionReconstructive sales grew 57% Y/Y on a reported basis and 9% on a Comparable basisReported third-quarter net loss from continuing operations of $0.61 per share, adjusted net income per diluted share of $0.73, up +30% Y/Y Wilmington, DE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for ...

November 6, 2024 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis to Host Third Quarter 2024 Results Conference Call on November ...

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results on Wednesday, November 6th, 2024 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call will be available on ir.enovis.com. Conference call/Webcast Information I...

October 10, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch